Docusign is a compelling 'growth at a reasonable price' play, benefiting from a strong Q2 beat, raised guidance, and improving sales execution. The company’s turnaround is evident in rebounding ...

As of 5 p.m. ET, DocuSign is now down 16%. As we’ve noted in prior updates, this likely is due to lower-than-expected billings guidance. The punishment to the stock is harsher than we would have ...

DocuSign (NASDAQ: DOCU) was one of the best-positioned companies to benefit from the pandemic. The company's e-signature platform boomed as industries that had resisted the technology had little ...

We are lowering our fair value estimate for narrow-moat DocuSign to $244 per share, from $290, as we have adjusted our model based on near-term guidance, which reduces our growth forecast over the ...

Investing.com -- Docusign reported quarterly results that topped Wall Street expectations and issued a revenue outlook that was in line with estimates. The company’s shares dipped more than 5% in ...

This side-by-side comparison of Adobe Sign and DocuSign will help you make an informed decisions based on features, pricing, pros and cons. E-signature solutions like Adobe Sign and DocuSign have ...